Rare phytocannabinoids (InMed Pharmaceuticals)

N/A

Report date: 2025/12/30 16:02:51

Base Information

Drug NameRare phytocannabinoids (InMed Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCannabinoid receptor modulatorsCannabinoid CB1 receptor antagonistsSerotonin 1a (5-HT1a) receptor antagonists +[4] 
TargetsCannabinoid receptorCannabinoid CB1 receptorAdrenergic receptors alpha-2 +[4] 
Therapy Area/IndicationsPsoriasisPruritusAcne Vulgaris +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsYes Cannabichromene (Cannabics Pharmaceuticals)TetrahydrocannabivarinCannabigerol (Axim Biotechnologies)
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInMed Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesInMed Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPsoriasisPruritusAcne Vulgaris +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A